topic

ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3
Yong-Qiang Ao, Jian Gao, Chun Jin, Shuai Wang, Li-Cheng Zhang, Jie Deng, Zong-wei Chen, Hai-Kun Wang, Jia-Hao Jiang, Jian-Yong Ding

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007766; DOI: 10.1136/jitc-2023-007766
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events
Karolina Gente, Leonore Diekmann, Lea Daniello, Julia Will, Manuel Feisst, Victor Olsavszky, Janine Günther, Hanns-Martin Lorenz, M Margarida Souto-Carneiro, Jessica C Hassel, Petros Christopoulos, Jan Leipe

Journal for ImmunoTherapy of Cancer Sep 2023, 11 (9) e007557; DOI: 10.1136/jitc-2023-007557
Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia
Shifaa M. Abdin, Daniela Paasch, Arnold Kloos, Marco Carvalho Oliveira, Mi-Sun Jang, Mania Ackermann, Andriana Stamopoulou, Philipp J Mroch, Christine S Falk, Constantin S von Kaisenberg, Axel Schambach, Michael Heuser, Thomas Moritz, Gesine Hansen, Michael Morgan, Nico Lachmann

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007705; DOI: 10.1136/jitc-2023-007705
Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis
Jason A Carter, Bharati Matta, Jenna Battaglia, Carter Somerville, Benjamin D Harris, Margaret LaPan, Gurinder S Atwal, Betsy J Barnes

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007935; DOI: 10.1136/jitc-2023-007935
Commentary on oncolytic viruses: past, present, and future
Christopher Larson, Bryan Oronsky, Tony R Reid

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007905; DOI: 10.1136/jitc-2023-007905
1475 Profiling cytokeratins in the tumor microenvironment using multiplex immunofluorescence
Danielle Fails, Michael Spencer

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) 1639; DOI: 10.1136/jitc-2023-SITC2023.1475
377 IL-15 treatment enhances the in vivo anti-tumor efficacy of sipuleucel-T by activating CD8+ T and NKT effector cells, augmenting tumor infiltration, and reversing immunoresistance pathways
Russell Pachynski, Muhammad A Saeed, Bo Peng, Kevin Kim, Ariel Borkowski, Brian Van Tine, Nadeem Sheikh, Tuyen Vu, Daniel Thorek, Todd Fehniger

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) 426; DOI: 10.1136/jitc-2023-SITC2023.0377
379 Epi-R^TM P2 protocol produces a scalable polyclonal TIL product with a greater expansion success rate across hot and cold tumors in shorter culture time
Yogin Patel, Jaewon Yun, Melissa Bedard, Melissa DeFrancesco, Carson Harms, Benjamin Harris, Saeed Azimi, Ngoc-Han Ha, Audrey Garces, Shobha Potluri, Gary Lee, Suman Vodnala

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) 428; DOI: 10.1136/jitc-2023-SITC2023.0379
425 A novel dendritic cell vaccine utilizing mannan anchored to irradiated tumor cells in the presence of immune adjuvants
Mitchell Y Sun, Alex Valenzuela, Juan Ye, Herui Wang, Yaping Zhang, Xueyu Sang, Zhengping Zhuang

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) 475; DOI: 10.1136/jitc-2023-SITC2023.0425
644 A phase 1 dose escalation study of GCC19CART – A novel CoupledCAR® therapy for subjects with metastatic colorectal cancer
Naifei Chen, Chengfei Pu, Lingling Zhao, Ning Li, Chang Wang, Yusheng Huang, Suxia Luo, Xun Li, Zhenzhou Yang, Jun Bie, Ruihong Zhu, Xi Huang, Haiyang Tang, Tingting Liang, Yizhuo Wang, Beibei Jia, Dongqi Chen, Victor Lu, Zhao Wu, Yongping Song, Lei Xiao, Jiuwei Cui

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) 737; DOI: 10.1136/jitc-2023-SITC2023.0644

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages